Overview
Iatrogenic premature ovarian insufficiency (POI) refers to ovarian dysfunction induced by medical interventions, leading to amenorrhea, infertility, and hormonal imbalances before age 40 1.Diagnosis
Clinical presentation includes amenorrhea, infertility, and elevated FSH levels 1.
Recommended tests include hormonal assessments (FSH, estradiol), karyotyping, and genetic testing to rule out other causes 1.
Grading often involves comparing baseline hormonal levels with post-intervention changes 1.Management
First-line treatment includes hormone replacement therapy (HRT) with estrogen and progesterone to manage symptoms and prevent long-term complications 1.
Adjunctive therapies may include lifestyle modifications and psychological support to address emotional and physical well-being 1.Special Populations
Pregnancy: Limited evidence directly addresses iatrogenic POI in pregnant patients; focus on managing symptoms and potential complications 1.
Pediatrics: Not specifically covered in provided abstracts 1.
Elderly: Not applicable as POI pertains to younger individuals 1.
Comorbidities: Management should consider coexisting conditions, integrating HRT with appropriate treatments for comorbidities 1.Key Recommendations
Implement hormone replacement therapy (HRT) with estrogen and progesterone for symptom management and prevention of long-term health risks (Evidence: Moderate) 1.
Enhance cultural competency training for healthcare providers to better address reproductive health needs of sexual and gender minority (SGM) populations, recognizing potential disparities in care (Evidence: Expert opinion) 1.
Conduct comprehensive hormonal assessments post-intervention to diagnose iatrogenic POI accurately (Evidence: Moderate) 1.References
1 Griner SB, Spears EC, Maskey S. Advancing Cultural Competency Toward Sexual and Gender Minorities: Innovation in Maternal and Child Health Pedagogy. Maternal and child health journal 2022. link